Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
4 pending office actions • 2 art units • 3 examiners • 0 of 4 (0%) have an AI response strategy ready
Tesla Biohealing Inc. currently has 4 pending office actions within the Chemistry & Materials technology area. These actions are assigned to 3 distinct examiners and are distributed across 2 distinct art units. This indicates a concentrated prosecution effort where a small group of examiners is responsible for reviewing the company's chemical and material innovations. Such a structure can facilitate a more consistent exchange between the applicant and the patent office.
The busiest examiner for this portfolio is GWARTNEY, ELIZABETH A, who is handling 2 pending office actions. This means that half of the 4 pending office actions are under the supervision of a single examiner. The remaining actions are split between the other 2 distinct examiners. This concentration under GWARTNEY, ELIZABETH A within the 2 distinct art units allows for a focused legal strategy that can prioritize the preferences and feedback of this specific examiner.
Practitioners should closely monitor the 2 pending office actions assigned to GWARTNEY, ELIZABETH A, as her decisions will have a significant impact on the overall portfolio in the Chemistry & Materials sector. With only 3 distinct examiners to manage, the company can develop a more personalized approach to prosecution compared to larger portfolios. The 2 distinct art units provide a stable technical environment for resolving the 4 pending office actions currently on the docket.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (75%) |
| Double-patenting only | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GWARTNEY, ELIZABETH A | 2 | 36.0% | +34.8% |
| ARNOLD, ERNST V | 1 | 48.2% | +12.9% |
| TRUONG, QUANGLONG N | 1 | 78.8% | +23.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18780610 | Devices for Treating Diseases and Conditions | ARNOLD, ERNST V | — |
| 18735463 | BIOENERGY (BIOPHOTON) GENERATOR AND ITS USE | TRUONG, QUANGLONG N | — |
| 18380727 | Bioenergy (Biophoton) Generator and its Use | GWARTNEY, ELIZABETH A | — |
| 18374040 | A Bioenergy (Biophoton) Generator and its Use | GWARTNEY, ELIZABETH A | — |
| Art Unit | Apps |
|---|---|
| 1759 | 2 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18780610 | Devices for Treating Diseases and Conditions | ARNOLD, ERNST V | — | DP | Non-Final OA | — | Pending | Jul 23, 2024 |
| 18735463 | BIOENERGY (BIOPHOTON) GENERATOR AND ITS USE | TRUONG, QUANGLONG N | 1615 | §103 | Non-Final OA | — | Pending | Jun 06, 2024 |
| 18380727 | Bioenergy (Biophoton) Generator and its Use | GWARTNEY, ELIZABETH A | 1759 | §103 | Non-Final OA | — | Pending | Oct 17, 2023 |
| 18374040 | A Bioenergy (Biophoton) Generator and its Use | GWARTNEY, ELIZABETH A | 1759 | §103 | Non-Final OA | — | Pending | Sep 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial